N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 23.5 CNY -6.67% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Nanjing Vazyme Biotech Co Ltd?
Write Note

Nanjing Vazyme Biotech Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing Vazyme Biotech Co Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Other Operating Expenses
ÂĄ97.1m
CAGR 3-Years
159%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Operating Expenses
ÂĄ210.1m
CAGR 3-Years
12%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Operating Expenses
ÂĄ45.2m
CAGR 3-Years
-7%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other Operating Expenses
ÂĄ20m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Operating Expenses
-ÂĄ96.3m
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
-8%
Imeik Technology Development Co Ltd
SZSE:300896
Other Operating Expenses
ÂĄ25.6m
CAGR 3-Years
147%
CAGR 5-Years
72%
CAGR 10-Years
N/A
No Stocks Found

Nanjing Vazyme Biotech Co Ltd
Glance View

Market Cap
9.3B CNY
Industry
Biotechnology

Nanjing Vazyme Biotech Co., Ltd. engages in the research and development, and production of antibody drugs. The company is headquartered in Nanjing, Jiangsu and currently employs 1,409 full-time employees. The company went IPO on 2021-11-15. The firm's main business is the technology research and development and product development of functional proteins such as enzymes, antigens, antibodies, and polymer organic materials. The firm's products include polymerase chain reaction (PCR), reverse transcription, gene sequencing series and other biological reagent products, quantum dot immunofluorescence reagents, latex enhanced immune turbidity reagents and colloidal gold immunochromatography reagents and other point-of-care testing (POCT) Diagnostic reagents and instruments.

Intrinsic Value
23.45 CNY
Fairly Valued
Intrinsic Value
Price
N

See Also

What is Nanjing Vazyme Biotech Co Ltd's Other Operating Expenses?
Other Operating Expenses
97.1m CNY

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Other Operating Expenses amounts to 97.1m CNY.

What is Nanjing Vazyme Biotech Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
70%

The average annual Other Operating Expenses growth rates for Nanjing Vazyme Biotech Co Ltd have been 159% over the past three years , 70% over the past five years .

Back to Top